SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
Structural basis for integration of GluD receptors within synaptic organizer complexes.
|
27418511 |
2016 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
GRID2 mutations span from congenital to mild adult-onset cerebellar ataxia.
|
25841024 |
2015 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
GRID2 mutations span from congenital to mild adult-onset cerebellar ataxia.
|
25841024 |
2015 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
GRID2 mutations span from congenital to mild adult-onset cerebellar ataxia.
|
25841024 |
2015 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18
|
0.900 |
GermlineCausalMutation
|
disease |
ORPHANET |
A homozygous deletion in GRID2 causes a human phenotype with cerebellar ataxia and atrophy.
|
23611888 |
2013 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18
|
0.900 |
Biomarker
|
disease |
MGD |
Deletions in GRID2 lead to a recessive syndrome of cerebellar ataxia and tonic upgaze in humans.
|
24078737 |
2013 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
A homozygous deletion in GRID2 causes a human phenotype with cerebellar ataxia and atrophy.
|
23611888 |
2013 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
Deletions in GRID2 lead to a recessive syndrome of cerebellar ataxia and tonic upgaze in humans.
|
24078737 |
2013 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Cbln1 is a ligand for an orphan glutamate receptor delta2, a bidirectional synapse organizer.
|
20395510 |
2010 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18
|
0.900 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Colorectal Carcinoma
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Ataxia, Spinocerebellar
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Spinocerebellar Ataxia Type 1
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Spinocerebellar Ataxia Type 2
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Spinocerebellar Ataxia Type 4
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Spinocerebellar Ataxia Type 5
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Spinocerebellar Ataxia Type 6 (disorder)
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Spinocerebellar Ataxia Type 7
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Cerebral atrophy
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Homozygous GRID2 missense mutation predicts a shift in the D-serine binding domain of GluD2 in a case with generalized brain atrophy and unusual clinical features.
|
29207948 |
2017 |
Global developmental delay
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Monoallelic or biallelic GRID2 mutations were recently reported in rare cases with cerebellar syndrome and variable degree of ataxia, ocular symptoms, hypotonia and developmental delay.
|
29207948 |
2017 |
Brain atrophy
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Homozygous GRID2 missense mutation predicts a shift in the D-serine binding domain of GluD2 in a case with generalized brain atrophy and unusual clinical features.
|
29207948 |
2017 |
Cerebellar atrophy
|
0.110 |
Biomarker
|
disease |
BEFREE |
However, the progressive and severe cerebellar atrophy seen in the affected individuals could indicate an evolutionarily unique role for GRID2 in the human cerebellum.
|
24078737 |
2013 |
Cerebral atrophy
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Global developmental delay
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|